Inflammatory cytokine mediator synthesis

The term "Inflammatory cytokine mediator synthesis" refers to the biological process in which immune and non-immune cells generate and secrete cytokines that mediate inflammation. Principal cytokines involved in this process include interleukin-1 (IL-1), interleukin-6 (IL-6), tumor necrosis factor alpha (TNF-α), and interferon gamma (IFN-γ). These molecules are produced primarily by macrophages, monocytes, T cells, and other immune cells in response to infection, injury, or immune activation[1][2][4]. Their synthesis and release are tightly regulated at the transcriptional and posttranscriptional levels, as excessive cytokine production leads to harmful inflammation and is implicated in diverse diseases including sepsis, autoimmune disorders, and cancer[3][5]. This process should not be considered a unique drug target, but rather a key physiological and pathological pathway involving multiple druggable targets. This entry is not specific enough to function as a canonical or structured drug target. For structured purposes, refer to specific cytokines (e.g., "Interleukin-6", "Tumor necrosis factor alpha"), their receptors, or the enzymes and pathways regulating their synthesis.

Other names

Pro-inflammatory cytokine synthesiscytokine productioninflammatory mediator biosynthesis